Traduction de «Rejet de greffe allogénique » (Français → Anglais) :

Human normal immunoglobulin (ivig) || Kiovig || 2011 || Extension of indication to include treatment of multifocal motor neuropathy and hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation in adults and children

The morbidity and mortality of patients waiting for transplantation require careful consideration of those potential donors who would normally not be considered as ideal candidates; these are called expanded donors (i.e. allowing transplants from HIV positive patients to other HIV positive patients.) When the donor pool is expanded in this way, doctors are concerned with increased likelihood of rejection of the organs and gradual decline of the function of the grafted organ.

17. Recognises that when the donor pool is expanded, doctors may be concerned about the increased likelihood of rejection of the organs and gradual decline of the function of the grafted organ, and therefore asks the Commission and Member States to support methods to prevent and treat organ rejection so that the “expanded” organ pool can be used with confidence by doctors;

By applications lodged at the Court Registry on 6 December 2001, Procter Gamble Company (‘Procter Gamble’) appealed pursuant to Article 49 of the EC Statute of the Court of Justice against the judgments of the Court of First Instance of 19 September 2001 in Case T-128/00 Procter Gamble v OHIM (Square tablet with inlay) [2001] ECR II-2785 (‘Case T-128/00’) and Case T‑129/00 Procter Gamble v OHIM (Rectangular tablet with inlay) [2001] ECR II-2793 (‘Case T‑129/00’), (together hereinafter referred to as ‘the judgments under appeal’), by which the Court of First Instance partially dismissed its actions for annulment of the decisions of the Third Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (‘OH ...[+++]IM’) of 8 March 2000 (Cases R‑506/1999‑1 and R‑508/1999‑1), which had rejected its appeals against the refusal to register as Community trade marks three-dimensional tablets for washing machines or dishwashers (‘the contested decisions’).

Have access to a serum bank that maintains at least one sample from each allogeneic donor for a minimum period of 2 years from the distribution of the last anatomical piece of the donor, so that required tests can be performed after grafting;

Have access to a serum bank that maintains at least one sample from each allogeneic donor for a minimum period of 2 years from the distribution of the last anatomical piece of the donor, so that required tests can be performed after grafting;